Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Free Cash Flow (2018 - 2025)

Historic Free Cash Flow for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $61.9 million.

  • TransMedics' Free Cash Flow rose 24983.07% to $61.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.6 million, marking a year-over-year increase of 20011.2%. This contributed to the annual value of -$80.9 million for FY2024, which is 5090.77% up from last year.
  • Latest data reveals that TransMedics reported Free Cash Flow of $61.9 million as of Q3 2025, which was up 24983.07% from $82.5 million recorded in Q2 2025.
  • Over the past 5 years, TransMedics' Free Cash Flow peaked at $82.5 million during Q2 2025, and registered a low of -$114.6 million during Q3 2023.
  • Moreover, its 5-year median value for Free Cash Flow was -$9.6 million (2023), whereas its average is -$11.6 million.
  • As far as peak fluctuations go, TransMedics' Free Cash Flow crashed by 56575.64% in 2023, and later skyrocketed by 412168.8% in 2025.
  • Over the past 5 years, TransMedics' Free Cash Flow (Quarter) stood at -$9.8 million in 2021, then skyrocketed by 30.8% to -$6.8 million in 2022, then plummeted by 392.93% to -$33.5 million in 2023, then surged by 118.07% to $6.1 million in 2024, then surged by 922.77% to $61.9 million in 2025.
  • Its last three reported values are $61.9 million in Q3 2025, $82.5 million for Q2 2025, and -$29.9 million during Q1 2025.